Multidisciplinary Management of Morbidities Associated with Chronic Graft-Versus-Host DiseaseRahul Shah, Bhagirathbhai Dholaria, Salyka Sengsayadeth et al.|Clinical Hematology International|2024Cited by 18
Use of Standardized Comprehensive Geriatric Assessment Identifies Areas of Unique Vulnerabilities in Older Adults Prior to Allogeneic Stem Cell Transplant (Allo-SCT)Reena Jayani, Adetola A. Kassim, Hina Budhwani et al.|Transplantation and Cellular Therapy|2022Cited by 0
HEALTHCARE UTILIZATION IN OLDER ADULTS (≥70 YEARS) UNDERGOING CELLULAR THERAPY FOR HEMATOLOGIC MALIGNANCIESChristina Snider, Reena Jayani, Hina Budhwani et al.|Innovation in Aging|2022Cited by 0
ABO Incompatibility Did Not Impact Outcomes after Haploidentical Bone Marrow Transplantation with Posttransplant Cyclophosphamide for Patients with Sickle Cell Disease: Single Center ExperienceDanielle Murphy, Adetola A. Kassim, Karina Wilkerson et al.|Transplantation and Cellular Therapy|2023Cited by 0
Vulnerabilities Older Adults Impact Chimeric Antigen Receptor T-Cell Therapy (CAR-T) OutcomesRachel Gorham, Reena Jayani, Olalekan O. Oluwole et al.|Transplantation and Cellular Therapy|2025Cited by 0